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Introduction
Benzo [a] pyrene (BaP) is a polycyclic aromatic hydrocarbon (PAH) that has been classified as human carcinogen (Group 1) by the International Agency for Research on Cancer (IARC, 2010) . BaP and other PAHs are produced mainly by incomplete combustion of organic matter and are ubiquitous in the environment, leading to measurable levels of exposure in the general population (IARC, 2010) . Beside the inhalation of polluted air, the main sources of exposure are tobacco smoke and the diet (Kim et al., 2011; Labib et al., 2012; Phillips and Venitt, 2012; Sidden et al., 2012) . Chronic exposure of laboratory animals to BaP has been associated with the development of cancer, primarily skin, stomach and lung (IARC, 2010) .
BaP requires metabolic activation prior to reaction with DNA (Baird et al., 2005) .
Cytochrome P450 (CYP) enzymes, mainly CYP1A1 and 1B1, are the most important enzymes in this process (Baird et al., 2005; Hamouchene et al., 2011) , in combination with microsomal epoxide hydrolase (mEH). First, CYP1A1 or 1B1 enzymes oxidize BaP to an epoxide that is then converted to a dihydrodiol by mEH (i.e. ; then further bioactivation by CYP1A1 or 1B1 leads to the ultimately reactive species that can react with DNA, forming adducts preferentially at guanine residues. The 10-(deoxyguanosin-N 2 -yl) -7,8,9-trihydroxy-7,8,9,10-tetrahydrobenzo[a] pyrene (dG-N 2 -BPDE) adduct is the major product of BPDE with DNA in vitro and in vivo (Phillips, 2005) . BaP is, however, oxidized also to other metabolites such as the other dihydrodiols, BaP-diones and hydroxylated metabolites (Bauer et al., 1995; Chun et al., 1996; Kim et al., 1998; Jiang et al., 2007; Zhu et al., 2008) . Among them, 3-hydroxy-BaP (BaP-3-ol), formed by CYP1A1, is considered the major detoxification product of BaP oxidation, because it is known to inhibit mutagenesis and tumorigenesis (Huang et al., 1986) .
In mouse hepatoma Hepa1c1c7 cells, which express inducible CYP1A1, this metabolite was the major metabolite formed after exposure to BaP (Holme et al., 2007) . Even though this CYP1A1-mediated BaP oxidation product as well as most of the other BaP metabolites are detoxification products, 9-hydroxy-BaP (BaP-9-ol) is a precursor of 9-hydroxy-BaP-4,5-epoxide ( Fig. 1 ) which can form another adduct with guanine (Schoket et al., 1989; Nesnow et al., 1993; Fang et al., 2003) . Thus, the levels and activities of CYP1A1 seem to be crucial both for the initiation of BaP-mediated carcinogenesis and BaP detoxification. The expression of CYP1A1 is known to be up-regulated by the aryl hydrocarbon receptor (AHR) and BaP can bind to and activate AHR thereby enhancing its own metabolic activation (Hockley et al., 2007) .
The level of BaP-DNA adducts in cells is most probably the result of a balance between their formation and their loss through either DNA repair processes, or cell turnover.
Collectively, BaP genotoxicity depends on various factors: (i) metabolism of BaP by phase I enzymes (activation) to reactive DNA-binding species; (ii) detoxification of reactive BaP metabolites by both phase I and phase II enzymes (conjugation); (iii) rate of repair of BaP-DNA adducts; and (iv) BaP-induced expression of genes such as those encoding enzymes involved in activation/detoxification or in DNA damage response (Uno et al., 2004) .
Recently, controversial results have been found showing a more important role of CYP1A1 in BaP detoxification in vivo than in its activation (Uno et al., 2004; Arlt et al., 2008; . Cyp1a1(−/−) mice treated with repeated oral doses of BaP (125 mg/kg body weight [bw]/day), die within ~28 days due to immune suppression, whereas wild-type (WT) mice remain healthy for at least 1 year on this regimen (Uno et al., 2004) . Using the Hepatic P450 Reductase Null (HRN) and the Reductase Conditional Null (RCN) mouse models we also showed that hepatic CYP enzymes appear to be more important for detoxification of BaP in vivo (Arlt et al., 2008; . In these mice NADPH:P450 oxidoreductase (POR), the essential electron donor to CYPs is deleted specifically in hepatocytes, resulting in a decrease in hepatic CYP function (Henderson et al., 2003; Finn et al., 2007) . We found however that the levels of dG-N 2 -BPDE adducts in livers of these mice treated with BaP were higher than in WT mice (Arlt et al., 2008; .
We postulate that the reason for these unexpected findings could be found in vitro by analyzing the roles of the different contributing enzymes at different ratios to each other. This can be achieved in reconstituted systems where single enzymes can be added at definite amounts without interference from other constituents as in microsomal systems. These data were compared with the metabolism of BaP and its activation to BaP-DNA adducts in vivo.
We evaluated CYP1A1-mediated BaP metabolism and its bioactivation in mouse hepatic microsomes and by recombinant CYP1A1 reconstituted with POR. Because microsomal cytochrome b 5 has been found to participate in transfer of electrons to CYP enzymes during the CYP catalysis or cause allosteric changes in CYP protein structures that can augment the CYP mediated reactions (Porter, 2002; Schenkman and Jansson, 2003; Guengerich, 2005; Stiborová et al., 2006; Kotrbová et al., 2011; Riddick et al., 2013) , we also analyzed its effects on BaP oxidation in the reconstituted system of CYP1A1 with POR. Moreover, since mEH is essential for the formation of the dG-N 2 -BPDE adduct (Kim et al., 1998; Baird et al., 2005) , its influence upon BaP-DNA adduct levels formed in a CYP1A1 reconstituted system was also elucidated. The levels of CYP1A1, POR, cytochrome b 5 and EH in mouse hepatic microsomes were determined in previous studies (Arlt et al., 2008; . In the present work,
we used a wide range of various ratios of these enzymes in the reconstituted systems to analyze their individual contribution to oxidation/activation of BaP. Among them, at least the reconstitution systems containing low concentrations of POR likely mimic the situation in the tested hepatic microsomes or in vivo. The formation of BaP metabolites was measured by high pressure liquid chromatography (HPLC) with UV-detection. DNA adduct formation was investigated by the thin-layer chromatography (TLC)-32 P-postlabeling method.
Material and Methods

Chemicals
BaP (>96%) was purchased from Sigma-Aldrich (St. Louis, MO). All other chemicals were of analytical purity or better.
Animal experiments
All animal experiments were carried out under license in accordance with the law, and with local ethical approval. HRN (Por lox/lox /Cre ALB ) mice on a C57BL/6 background were derived as described previously (Henderson et al., 2003) . BaP was dissolved in corn oil at a concentration of 12.5 mg/ml. Groups of female HRN mice (3 months old, 25-30 g, n=3) were treated intraperitoneally with 125 mg/kg bw of BaP for five days. Control mice received corn oil only (Arlt et al., 2008) . Animals were killed 24 h after the last dose. Livers were removed, snap frozen and stored at −80 o C until analysis.
Preparation of microsomes
Hepatic microsomes were isolated as described previously (Arlt et al., 2008) and pooled for further experiments. Protein concentration in the microsomal fraction was measured using bicinchoninic acid protein assay (Wiechelman et al., 1988) with bovine serum albumin as a standard.
Isolation of CYP1A1, POR, cytochrome b 5 and mEH
Recombinant rat CYP1A1 protein was purified to homogeneity from membranes of Escherichia coli transfected with a modified CYP1A1 cDNA (Stiborová et al., 2002) by P. Hodek (Charles University, Prague, Czech Republic). Rabbit liver POR was purified as described (Stiborová et al., 2002) . Cytochrome b 5 was isolated from rabbit liver microsomes by the procedure described by Roos (1996) . mEH was purified from liver microsomes of rabbits pretreated with phenobarbital as described by Ariyoshi et al. (1994) . These enzymes were used for the CYP1A1 reconstitution experiments. As shown in our previous studies (Stiborová et al., 2002; Kotrbová et al., 2009; , the enzymatic activity of rat or human CYP1A1 reconstituted with rabbit POR and cytochrome b 5 was essentially the same as that of the enzyme reconstituted with the rat orthologs of these enzymes.
Microsomal and enzymatic incubations
Incubation mixtures used to study BaP metabolism in mouse hepatic microsomes or by purified CYP1A1 (100 pmol) reconstituted with POR (5-150 pmol), with or without cytochrome b 5 (100-500 pmol), with or without mEH (20-250 pmol) contained 100 mM potassium phosphate buffer (pH 7.4), NADPH-generating system (1 mM NADP + , 10 mM D-glucose-6-phosphate, 1 U/ml D-glucose-6-phosphate dehydrogenase), 0.5 mg of microsomal protein or 100 pmol CYP1A1 in the reconstituted system, 50 µM BaP (dissolved in 5 µl dimethyl sulfoxide) in a final volume of 500 µl. The enzyme reconstitution was performed as described [(Stiborová et al., 2002; Kotrbová et al., 2011) , using different molar ratios of CYP1A1 to POR and cytochrome b 5 and/or mEH (see Results for details). Incubation mixtures used to analyze BaP-induced DNA adduct formation were as described above but contained 1 mM NADPH instead of the NADPH-generating system plus 1 mg calf thymus DNA. The reaction was initiated by adding BaP. Incubations were carried out at 37°C for 90 min; BaP-DNA adduct formation was linear up to 120 min (Arlt et al., 2008) . Control incubations were carried out either without CYP, without NADPH, without DNA, or without BaP. After the incubation, DNA was isolated from the residual water phase by the phenol/chloroform extraction method as described (Stiborová et al., 2002) .
CYP1A1 enzyme activity assays
The samples containing CYP1A1 reconstituted with POR (see the procedure described above) were characterized for enzyme activity using Sudan I oxidation for CYP1A1 (Stiborová et al., 2002) and 7-ethoxyresorufin O-deethylation (EROD) for CYP1A (Guengerich and Shimada, 1991) . The conditions used for the chromatographic separation of BaP metabolites were as follows:
HPLC analysis of BaP metabolites
50% acetonitrile in water; (v/v), with a linear gradient to 85% acetonitrile in 35 min, then an isocratic elution with 85% acetonitrile for 5 min, a linear gradient from 85% acetonitrile to 50% acetonitrile in 5 min, followed by an isocratic elution of 50% acetonitrile for 5 min.
Detection was by UV absorption at 254 nm. BaP metabolite peaks ( Fig. 2A ) were collected and analyzed by NMR and/or mass spectrometry. The areas under the curve at 254 nm were calculated relative to the peak area of the internal standard phenacetin and expressed as relative peak areas. However, the signals of the two two-spin systems (H-4,H-5 and H-11, H-12) could not be assigned with the use of COSY spectrum only and heteronuclear correlation spectra (HSQC and HMBC) had to be used. The assignment of all 1 H signals and coupling constants of BaP and its metabolites is shown in Table 1 (for structures see Fig 2B) .
2) M1. Two signals of the four-spin system of M1 were shifted upfield (to 4.5 and 5.7 ppm). These values are too low for the fully aromatic BaP skeleton. The structure of M1 was identified as trans-9,10-dihydro-BaP-9,10-diol (BaP-9,10-dihydrodiol) by comparison with previously reported NMR data of this compound (Platt and Oesch, 1983) . The trans arrangement of the two hydroxy groups was supported by the inspection of the vicinal coupling constant between hydrogen atoms H-9 and H-10. The torsion angle between these two hydrogen atoms calculated using the generalized Karplus type equation (Haasnoot et al., 1980 ) was predicted to be 48º. This value is very close to the torsion angle observed in the molecular model of the trans-derivative with the two hydroxyl groups in pseudo-axial positions. The molecular model of the cis-derivative predicts the torsion angle between the two hydrogen atoms to be close to −75º. We were unable to determine the absolute configuration on the new asymmetric centers (C-9 and C-10). It is possible that both enantiomers are present in metabolite M1.
3) M4 and M5. In the spectra of both compounds we observed the four-spin system of H-7, H-8, H-9 and H-10 and three two-spin systems. Two substituents are therefore attached to the BaP skeleton: one in position 6 and the second one in position 1 or 3. Furthermore, the unusually shielded H-2 proton at 6.7 ppm was characteristic of the α-proton (next to carbonyl) in phenalones (Prinzbach et al., 1967) suggesting that the structures of M4 and M5
could be BaP-1,6-dione and -3,6-dione, respectively. Because both compounds were synthesized previously and their 1 H NMR spectra was reported (Leeruff et al., 1986; Xu et al., 2009 ), spectra in CDCl 3 were used for comparison and the metabolites could be identified as
BaP-1,6-dione (M4) and BaP-3,6-dione (M5).
4) M7.
In the spectrum of M7, the three-spin system was replaced with a two-spin system suggesting that one substituent is attached to the position 1 or 3 of the BaP. The structure of M7 was confirmed to be BaP-3-ol by comparison of the chemical shifts and coupling constants with those reported previously (Xu et al., 2009 ).
5) M2, M3 and M6. Because the amounts of M2, M3 and M6 samples were insufficient for NMR spectroscopy, these metabolites were analyzed only by mass spectrometry only as described below.
Mass spectrometry
Mass spectra of BaP and its metabolites M2, M3 and M6 were measured on a matrix- (Bauer et al., 1995; Kim et al., 1998) , in which these metabolites were identified as BaP-4,5-dihydrodiol (M2), , and BaP-9-ol (M6).
BaP-DNA adduct detection by 32 P-postlabeling analysis
DNA adducts were measured using the nuclease P1 enrichment version of the TLC-32 Ppostlabeling method essentially as described previously (Arlt et al., 2008; Phillips and Arlt, 2007) . Briefly, DNA samples (4 µg) were digested with micrococcal nuclease (120 mU; Sigma) and calf spleen phosphodiesterase (40 mU; Calbiochem), enriched and labeled as reported. Solvent conditions for the resolution of developments to the top of the plates, the plates were developed an additional 30 min with the TLC tank partially opened, to prolong the resolution time of the BaP-DNA adducts. After chromatography TLC plates were scanned using a Packard Instant Imager (Dowers Grove, IL, USA). DNA adduct levels (RAL, relative adduct labeling) were calculated as described (Arlt et al., 2008) . Results were expressed as DNA adducts/10 8 nucleotides. An external BPDE-experimental samples.
Results
Oxidation of BaP by hepatic microsomes and CYP1A1 reconstituted with POR, cytochrome b, and mEH
BaP metabolism in the CYP1A1 reconstituted system containing POR combined with cytochrome b 5 and/or mEH was compared with its metabolism by hepatic microsomes isolated from control (untreated) and BaP-pretreated HRN mice. In studies using mouse hepatic microsomes, a spectrum of hydroxylated BaP metabolites, BaP-dihydrodiols as well as BaP diones (quinones) was found (Fig. 2) . Seven BaP oxidation products (designated as M1-M7) were generated both by hepatic microsomes of control HRN mice and by those with induced CYP1A1 expression mediated by pretreating HRN mice with BaP. These metabolites have been reported to be formed by CYP1A1 in combination with mEH (Bauer et al., 1995; Kim et al., 1998; Baird et al., 2005) . The HPLC method using an acetonitrile/water gradient as mobile phase and UV detection at 254 nm resulted in mostly base-line separation of all BaP metabolites ( Fig. 2A) .
The BaP metabolites formed by mouse hepatic microsomes were collected and subsequently characterized by NMR or mass spectrometry. They were identified to be BaP-
, BaP-3,6-dione (M5), BaP-9-ol (M6), and BaP-3-ol (M7) (see Fig. 2 ). Very low expression levels of mouse Por in the liver of untreated HRN mice that constitutively express Cyp1a1 (Arlt et al., 2008) resulted in the formation of very low amounts of these BaP metabolites. However, Cyp1a1 induction by BaP pretreatment of HRN mice (Arlt et al., 2008) was sufficient for the effective oxidation of BaP by hepatic microsomes, even at the very low Por concentrations in these microsomes (Fig. 3) . The efficiency of these microsomes to oxidize BaP to BaP-7,8-dihydrodiol, the precursor of BPDE, was more than 34-fold higher than that of microsomes of untreated mice, while formation of other metabolites was less pronounced. Amounts of BaP-9,10-dihydrodiol, BaP-4,5-dihydrodiol, BaP-1,6-dione, BaP-3,6-dione, BaP-9-ol and BaP-3-ol were 6.6-, 9.6-, 2-, 3.4-, 10-and 7.7-times higher, respectively, in microsomes of HRN mice exposed to BaP than in those of untreated HRN mice (Fig. 3) .
To investigate the role of CYP1A1 in oxidation of BaP to individual metabolites, purified CYP1A1 was reconstituted with POR and used as the oxidation system. CYP1A1
reconstituted with POR was active with its typical substrates, Sudan I (Stiborová et al., 2002) and 7-ethoxyresorufin (Guengerich and Shimada, 1991 ) (data not shown). Isolated CYP1A1 reconstituted with POR oxidized BaP to only four metabolites, namely BaP-1,6-dione (M4),
BaP-3,6-dione (M5), BaP-9-ol (M6), and BaP-3-ol (M7) (Fig. 4) . As expected, no BaPdihydrodiols were detected in this system because of the absence of mEH which is important for the hydration of BaP epoxides. In the enzymatic systems where mEH was reconstituted with CYP1A1 and POR, BaP-9,10-dihydrodiol (M1) and BaP-7,8-dihydrodiol (M3) were formed as expected, however the whole metabolic profile of BaP could not be quantified because some impurities in the mEH preparation interfered with BaP metabolites eluting between 22 and 35 min during HPLC (data not shown).
Interestingly, no significant differences in levels of BaP-1,6-dione, BaP-3,6-dione and BaP-9-ol were found in the systems where CYP1A1 was reconstituted with low amounts of POR (the CYP1A1:POR ratio was 1:0.05) or equimolar concentrations of these enzymes (Fig. 4) . Only BaP-3-ol formation was significantly higher (1.6-fold) in the system containing equimolar CYP1A1:POR ratios. No BaP metabolites were formed when POR was omitted from the CYP1A1 reconstitution system (Fig. 4) . However, when CYP1A1 was reconstituted with cytochrome b 5 without POR (under CYP1A1:cytochrome b 5 ratios of 1:1, 1:2.5 or 1:5),
BaP was oxidized (Fig. 5A) to only low amounts of BaP-9-ol. Addition of cytochrome b 5 to the CYP1A1/POR reconstituted system led to a cytochrome b 5 -concentration-dependent increase in BaP oxidation (compare Fig. 4 and Fig. 5B and C) ; the increase was found both at 1:0.05 and 1:1 CYP1A1:POR ratios. BaP-3-ol was the major metabolite formed under both CYP1A1:POR ratios but its amount was up to 1.8-fold higher when POR was present at an equimolar ratio to CYP1A1 than at the 1:0.05 CYP1A1:POR ratio. In contrast, the amount of BaP-9-ol was always higher in the system with low POR concentrations. Like BaP-3-ol, the amount of BaP-3,6-dione formed in the system was always higher at equimolar CYP1A1/POR concentrations relative to the systems containing low POR concentrations, while overall no differences were found for BaP-1,6-dione. Collectively, all these results indicate that cytochrome b 5 may contribute quite substantially to the CYP1A1-mediated oxidation of BaP, even under conditions with very low quantities of POR.
BaP-DNA adduct formation by hepatic microsomes and CYP1A1 reconstituted with POR, cytochrome b 5 and mEH
In further experiments the formation of BaP-derived DNA adducts was investigated in analogous enzymatic systems.
Activation of BaP by CYP1A1 reconstituted with POR in the presence of DNA resulted in the formation of only one BaP-DNA adduct (adduct spot 1 shown in Fig. 6A ). Therefore, this adduct is formed by CYP1A1-catalyzed oxidation of BaP, without the contribution of mEH.
Comparison with previous 32 P-postlabeling studies (Schoket et al., 1989; Nesnow et al., 1993; Fang et al., 2001) showed that adduct spot 1 has similar chromatographic properties on PEIcellulose TLC to a guanine adduct derived from reaction with 9-hydroxy-BaP-4,5-epoxide (see Fig. 1 ). In accordance with these previous results, DNA adduct 1 (Fig. 6 ) had more hydrophobic properties on PEI-cellulose than another BaP-derived DNA adduct (assigned adduct spot 2) formed by hepatic microsomes (compare Fig. 6D ), which was identified as dG-N 2 -BPDE (Schoket et al., 1989; Fang et al., 2001; Arlt et al., 2008) .
As shown in Figure 7A formation of BaP-DNA adduct 1 was dependent on the CYP1A1:POR ratio and was formed even at low POR concentrations (i.e. a CYP1A1:POR ratio of 1:0.2). However, when BaP was incubated with DNA using a CYP1A1:POR ratio of 1:2, lower levels of this adduct were produced (Fig. 7A) . Addition of increasing amounts of mEH to the CYP1A1/POR reconstituted system led to a decrease in the formation of this adduct, while BaP-DNA adduct 2 (adduct spot 2 shown in Figure 6B and 6D) was generated (Figs. 7B, 8A and 8C) . No BaP-DNA adducts were detected by 32 P-postlabeling when NADPH, the cofactor of the NADPH-dependent CYP system, was omitted from incubations with the CYP1A1 reconstituted systems (Fig. 6C) .
Addition of cytochrome b 5 to the CYP1A1 reconstituted system resulted in increased formation of both BaP-DNA adducts formed under a CYP1A1:POR ratio of 1:2, both in the absence and presence of mEH (Fig. 8) . However, levels of BaP-DNA adduct 1 at a CYP1A1:POR ratio of 1:0.2 were nearly identical in the presence or absence of cytochrome b 5 when mEH was absent, whereas addition of cytochrome b 5 to this system in the presence of mEH increased formation of both BaP-DNA adducts (Figs. 8A and B) . The levels of adduct 1 formed by CYP1A1, POR and cytochrome b 5 in a ratio of 1:2:3 were higher than in any other enzyme combination (Fig. 8) . Among all enzyme combinations used, the highest levels of both BaP-DNA adducts were produced by the system containing CYP1A1, POR, mEH and cytochrome b 5 in a ratio of 1:2:0.5:3 (Fig. 8D ) followed by the systems containing these enzymes in ratios of 1:0.2:1:3 (Fig. 8B ) or 1:2:1:3 (Fig. 8D) . These results showed that even under low POR concentrations, CYP1A1 in the presence of appropriate concentrations of mEH and cytochrome b 5 efficiently activates BaP to DNA binding species. These results are in line with the BaP metabolite profile in the CYP1A1 reconstituted experimental systems described above.
The DNA adduct results obtained in reconstituted enzyme systems corresponded to those found in hepatic microsomes of HRN mice. As shown in our previous study (Arlt et al., detectable by 32 P-postlabeling. Using this method one major asymmetric BaP-DNA adduct spot was detectable, in which the dG-N 2 -BPDE adduct was identified by cochromatographic analysis, and DNA adduct levels increased substantially in incubations with microsomes from BaP pretreated HRN mice (Arlt et al., 2008) . After closer inspection of this asymmetric BaP-DNA adduct spot and improved chromatographic separation, two major BaP-DNA adducts (still partially overlapping one another) were detectable. Better separation of these BaP-DNA adducts as well as those found in liver of HRN mice treated with BaP was achieved on PEIcellulose TLC ( Fig. 6D and 6E ) by a slightly modified development in D3 and D4 directions as outlined in Material and Methods. The chromatographic properties of both adducts on TLC were similar to the two BaP-DNA adducts found in experiments utilizing CYP1A1-reconstituted systems (compare adduct spots 1 and 2 in Fig. 6B and 6D ). Therefore, in the present study we re-analyzed the BaP-DNA adduct levels found in hepatic microsomal incubations from control (untreated) HRN mice and those pretreated with BaP. While only low levels of both BaP-DNA adducts were formed by hepatic microsomes from untreated HRN mice, formation of both adducts increased substantially (~50-fold) in hepatic microsomes isolated from BaP-pretreated HRN mice (Fig. 9) . These results indicate that Cyp1a1 induction in combination with relative low Por expression still provides an efficient BaP activation system leading to DNA adduct formation. BaP-DNA adduct 1 was, however, hardly detectable in liver DNA from BaP-treated HRN mice (Fig. 6E ) which is in full concordance with results obtained previously (Arlt et al., 2008) where dG-N 2 -BPDE (assigned BaP-DNA adduct 2 in the present study) was the major adduct identified in vivo.
Discussion
Previously we worked with two different mouse models lacking Por expression in hepatocytes and found that the levels of BaP-DNA adducts were up to 13-fold higher in livers of HRN mice treated with BaP than in those of WT mice (Arlt et al., 2008) . More recently, these results were confirmed in the RCN mouse model BaP-9,10-dihydrodiol) as well as BaP diones (BaP-1,6-dione and BaP-3,6-dione). The same metabolites have been formed in several previous studies utilizing enzyme systems of CYP1A1 combined with POR and mEH (Kim et al., 1998; Jiang et al., 2007; Zhu et al., 2008) . We also found that BaP is activated by these microsomes to form BaP-DNA adducts (Fig. 6 ) which have been detected in previous studies (Nesnow et al., 1993; Schoket et al., 1989; Fang et al., 2001; Siddens et al., 2012) .
As expected, mEH was essential for the formation of BaP-dihydrodiols; CYP1A1 reconstituted with POR but without mEH generated only BaP-1,6-dione, BaP-3,6-dione, BaP-3-ol, and BaP-9-ol. It is known that oxidation of various substrates by CYP1A1 or other
CYPs is dependent on the POR:CYP1A1 ratio; optimal ratios of these enzymes are usually 1:1 or higher (Buters et al., 1995; Chun et al., 1996; Schwarz et al., 2001; Shimada et al., 1999; Yamazaki et al., 2001; Stiborová et al., 2002; Guengerich, 2005; Faroog and Roberts, 2010; Davydov, 2011; Kotrbová et al., 2011; Davydov et al., 2013) . Davydov, 2011) . This suggestion was supported by several investigations for substrate oxidation by various CYP enzymes in the reconstituted systems (Kaminsky and Guengerich, 1985; Backes et al., 1989; Iwase et al., 1991; Fernando et al., 2007; Davydov, 2011) . The reasons for the results found in the present work seem to be even more complex, as BaP oxidation by the CYP1A1 reconstituted system was substantially stimulated by cytochrome b 5 .
The major BaP-DNA adduct formed in HRN/RCN mice and in hepatic microsomes of HRN mice was previously identified by TLC, HPLC and LC-MS/MS to be dG-N 2 -BPDE. In addition, another adduct found and assigned adduct 1 in the present study, exhibited more hydrophobic properties on 32 P-postlabeling TLC (see Fig. 1 in Arlt et al., 2008 and Fig. 2 in Arlt et al., 2012) and could be separated from adduct 2 (i.e. dG-N 2 -BPDE). Since mouse hepatic Cyp enzyme activity had been largely obliterated by the permanent (HRN model) or conditional (RCN model) deletion of Por in hepatocytes, the levels of BaP-DNA adduct formation in livers in HRN or RCN mice in vivo and in hepatic microsomes of HRN mice ex vivo was difficult to rationalize (Arlt et al., 2008; . Previous results indicated that the process leading to DNA adducts did not involve the generation of a reactive species different from that formed in WT mice (Arlt et al., 2008; . Since the structure of the dG-N 2 -BPDE adduct formed in vivo was identified by mass spectrometry (Arlt et al., 2008) , BPDE ( Fig. 1) must be the reactive species formed both in HRN/RCN and WT mice. Moreover, enzymes different from CYPs such as cyclooxygenases were not found to be involved in BaP activation in these mouse models (Arlt et al., 2008) . Indeed, formation of dG-N 2 -BPDE by hepatic microsomes of HRN mice ex vivo, which depended on NADPH, and was attenuated by inhibitors of CYP1A1 (α-naphthoflavone, ellipticine) and POR (α-lipoic acid), supported this conclusion (Arlt et al., 2008) . Although the CYP specificity of chemical inhibitors can sometimes be problematic (Rendic and DiCarlo, 1997) , these results indicated that hepatic and present work]. In contrast, BaP-3-ol the major CYP1A1-mediated metabolite detoxicating BaP (Baird et al., 2005) only increased 7.7-fold after pretreatment of mice with BaP.
In this study two DNA adducts were generated by hepatic microsomes of HRN mice and levels of both were dependent on pretreatment of these mice with BaP, a CYP1A1 inducer.
When CYP1A1 reconstituted with POR only was used for BaP activation, one BaP-DNA adduct (assigned adduct 1; Fig. 6A ) was generated. After addition of mEH to the CYP1A1/POR reconstituted system, the dG-N 2 -BPDE adduct (assigned adduct 2; Fig. 6 ) was also formed. Again, higher amounts of both BaP-DNA adducts were formed by CYP1A1 in the presence of low POR levels (i.e. a ratio of CYP1A1:POR of 1:0.2) than at equimolar ratios in the reconstitution system. Moreover, cytochrome b 5 substantially stimulated BaP-DNA adduct formation. Both these BaP-DNA adducts have also been found by Schoket et al. adduct spots by TLC-32 P-postlabeling. The highly hydrophobic adduct 1 was tentatively identified by these authors as an adduct derived from 9-hydroxy-BaP-4,5-epoxide. This BaP metabolite is bound to the exocyclic amino group of a guanine residue, and the site of attachment is most likely either the 4 or the 5 position of BaP (Fang et al., 2003) . Analogous to our results, the formation of adduct 1 was independent of the activity of mEH; an inhibitor of this enzyme, 1,2-epoxy-3,3,3-trichloropropane, did not influence its formation (Schoket et al., 1989) . In contrast the formation of dG-N 2 -BPDE (adduct 2) was strongly inhibited by this mEH inhibitor. Nevertheless, even though a precursor of 9-hydroxy-BaP-4,5-epoxide, BaP-9-ol, was formed both in mouse hepatic microsomes and by the CYP1A1 reconstitution system, further work is required to demonstrate that adduct 1 is derived from 9-hydroxy-BaP-4,5-epoxide. The synthesis of an authentic standard should help with the structural identification.
It is well known that BaP is a strong CYP1A1 inducer in many organisms including HRN mice (Arlt et al., 2008) . BaP also induced expression of Por protein (by 2.9-fold) and the activity of this enzyme as well as mEH and cytochrome b 5 in HRN mice (Arlt et al., 2008; , thereby enhancing its own metabolic activation. Indeed, pretreatment of HRN mice with BaP led to more than ~50-fold higher DNA adduct levels ex vivo using hepatic microsomes (Fig. 9) . Because microsomal cytochrome b 5 influences the CYP1A1-mediated activation of BaP in vitro, and is induced by BaP treatment in HRN mice , cytochrome b 5 provides the second electron to CYP promptly after oxygen binding.
Cytochrome b 5 can also act as an allosteric modifier of the oxygenase (Porter, 2002; Schenkman and Jansson, 2003; Guengerich, 2005; Kotrbová et al., 2011; Stiborová et al., 2012; Riddick et al., 2013) . /Cre ALB ; HBN mouse) has been generated (Finn et al., 2008) with or without the expression of hepatic Por (Henderson et al., 2013) . In the future we plan to investigate the balance between Cyp-mediated activation and detoxification of BaP in vivo in these potentially improved mouse models. vivo. This might be caused, beside other factors, by differences in the DNA repair of the two adducts in vivo or due to efficient conjugation of the BaP-9-ol intermediate.
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